IHM
ADMS

Iguana Healthcare Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Iguana Healthcare Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$717K Buy
+30,000
New +$946K 0.47% 55
2016
Q3 		– Sell
-100,000
Closed -$1.51M – 107
2016
Q2 		$1.51M Sell
100,000
-100,000
-50% -$1.65M 0.62% 51
2016
Q1 		$2.89M Buy
200,000
+140,000
+233% +$2.36M 1.06% 29
2015
Q4 		$1.7M Buy
+60,000
New +$1.01M 0.56% 51

Other funds holding ADMS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Iguana Healthcare Management's ADMS Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Adamas Pharmaceuticals (ADMS) in Q1 2018: 30,000 shares worth $717K. The stake represents 0.47% of the portfolio and ranks #55 among its holdings. This is a return to the name: Iguana Healthcare Management previously reported a position in ADMS as recently as Q2 2016.

Iguana Healthcare Management first reported a position in ADMS in Q4 2015 and has held it in 4 quarters since. The position peaked at $2.89M in Q1 2016. 118 funds tracked by Wall St. Rank hold ADMS as of Q1 2018.

  • Iguana Healthcare Management held 30,000 shares of Adamas Pharmaceuticals worth $717K as of Q1 2018.
  • Adamas Pharmaceuticals was a new Iguana Healthcare Management position in Q1 2018.
  • Adamas Pharmaceuticals made up 0.47% of Iguana Healthcare Management's portfolio in Q1 2018, its #55 holding.
  • Iguana Healthcare Management first reported a position in Adamas Pharmaceuticals in Q4 2015 and has held it in 4 quarters since.
  • Iguana Healthcare Management's Adamas Pharmaceuticals position peaked at $2.89M in Q1 2016.
  • 118 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.